University Clinic Hamburg Eppendorf
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Degen, Olaf
VOLITION, NCT05917509: A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Active, not recruiting
3
171
Europe, Canada, US, RoW
DTG/3TC, Dovato, Cabotegravir (CAB) LA, Vocabria, Rilpivirine (RPV) LA, Rekambys
ViiV Healthcare, GlaxoSmithKline, PPD DEVELOPMENT, LP
HIV Infections
10/25
10/26
JUNGLE, NCT03518060: Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1

Completed
N/A
209
Europe
JULUCA
ViiV Healthcare, MUC Research GmbH
HIV Infections
05/23
05/23
URBAN, NCT03754803: Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany

Completed
N/A
366
Europe
HIV Symptom Distress Module Questionnaire, HIV treatment satisfaction questionnaire
ViiV Healthcare, MUC Research GmbH
HIV Infections
05/24
05/24
MISTRAL, NCT05421286: The Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events

Active, not recruiting
N/A
1000
Europe, RoW
Rigshospitalet, Denmark, IrsiCaixa, Horizon 2020 - European Commission
HIV-1-infection, Inflammation, AIDS
12/25
12/25

Download Options